DANIPHARM A/S

DANIPHARM A/S (CVR number: 12335040) is a company from TÅRNBY. The company recorded a gross profit of 35.2 mDKK in 2022. The operating profit was 8056.3 kDKK, while net earnings were 5390.8 kDKK. The profitability of the company measured by Return on Assets (ROA) was 10.9 %, which can be considered good and Return on Equity (ROE) was 13.9 %, which can be considered good. The equity ratio, a key indicator for solidity, stood at 47.6 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. DANIPHARM A/S's liquidity measured by quick ratio was 1.3 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.